Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Brexit: UK trade deal with US could trigger 'break-up' of NHS, leading expert warns

Exclusive: Professor Alex de Ruyter says Britain still has 10 per cent chance of staying in Europe

Tom Embury-Dennis
Monday 09 July 2018 13:54 EDT
Comments
Who is new Brexit Secretary Dominic Raab?

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Britain leaving the European Union could lead to the “break-up” of the NHS, one of the world’s leading Brexit experts has told The Independent.

Professor Alex de Ruyter, director of the Centre for Brexit Studies at Birmingham City University (BCU), warned any future trade deal with the US would mean American pharmaceutical companies looking to access the health service.

His warning comes just months after Theresa May stoked fears of an NHS “for sale” in a future trade deal with the US, after she refused to say it would be excluded from talks.

“The NHS is the biggest market for drugs, probably in the world,” Mr de Ruyter said. “It basically sets the price of pharmaceuticals in Europe. So outside of the EU, big pharma in the US will obviously want access to that, so you potentially could see the break-up of big chunks of the NHS.”

Warning about future trade disputes between Britain and America, the former director of BCU’s business school said the UK faced the prospect of opaque arbitration panels once it leaves the European Court of Justice‘s jurisdiction.

“They generally side with the company lodging the complaint against what they regard as anti-competitive government behaviour,” Mr de Ruyter said. ”Now, in the eyes of an American pharmaceutical company, the NHS is the ultimate anti-competitive government body.”

“We may have to compromise on the NHS, and open up tenders for NHS products and services to private sector competition,” he added.

David Davis wants post-Brexit relationship with Europe that 'recognises the history' and 'stands the test of time'

Research earlier this year revealed the proportion of health service contracts being won by non-NHS firms ballooned by almost 70 per cent in 2017. Private care providers were awarded 267 out of a total of 386 contracts made available in 2016-17 – taking spending up by £700m to £3.1bn.

Critics say this rising “privatisation” has already opened the door to US health firms, who view the NHS as a gold mine – even before talks on a trade deal after Brexit.

In February, Donald Trump gave a flavour of his thoughts on the NHS. “The Democrats are pushing for Universal HealthCare while thousands of people are marching in the UK because their U system is going broke and not working,” he tweeted.

America “doesn’t need a trade deal in the way that a post-Brexit UK outside of the customs union does”, Mr de Ruyter said.

“If you want a trade deal with the US you’ll have to embrace their framework. They’re not going to budge from that, they think they’re the superior negotiating party here, and to all intents and purposes they are.”

Mr Trump, he said, is “not really focused” on Britain, but on the “big beasts” of the global economy such as China and the EU.

“The UK is just another would-be supplicant country coming along knocking on the door wanting an arrangement.”

Mr de Ruyter also warned there was going to be no easy way to heal divides between Remain and Leave voters, regardless of any final settlement.

“There’s no evidence out there that people have moved on, and bringing them together implies that you can talk to each other, whereas people seem today even more entrenched in their views,” he said.

Despite the vote for Leave, he said there was “maybe a one in 10 chance” the country would remain in the EU. “I wouldn’t rule it out,” he added.

He condemned Ms May for her “have your cake and eat it” approach to negotiations with Europe, and warned the government were sooner or later going to have to choose between a clean break or a deal that would leave arch-Brexiteers unhappy.

“Theresa May’s function as a prime minister is management of expectations of her own cabinet. You’re trying to reconcile [Liam] Fox and [Philip] Hammond, and you can’t, so at some point the crunch will have to come and you’ll have to make a choice.”

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in